Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin for treatment of depression
IRCT20231207060286N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of niacin in major depressive disorder (MDD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jan 2024; status: completed.
02
Drugs
niacin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20231207060286N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231207060286N1.